Titan Medical Inc. (TMD.TO)
| Previous Close | 0.8700 |
| Open | 0.8500 |
| Bid | 0.7800 x 0 |
| Ask | 0.8000 x 0 |
| Day's Range | 0.7800 - 0.8500 |
| 52 Week Range | 0.7800 - 4.4000 |
| Volume | |
| Avg. Volume | 53,717 |
| Market Cap | 96.507M |
| Beta (5Y Monthly) | 4.57 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5730 |
| Earnings Date | Feb. 21, 2022 - Feb. 25, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Titan Medical Announces CEO Transition
TORONTO, December 01, 2021--Titan Medical Announces CEO Transition
- Business Wire
Titan Medical Reports Third Quarter 2021 Financial Results
TORONTO, November 11, 2021--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of its innovative surgical technologies for robotic-assisted surgery that requires a single patient access point, today announced financial results for the three and nine months ended September 30, 2021.
- Business Wire
Titan Medical Announces Expansion of Surgeon Advisory Board
TORONTO, November 03, 2021--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced changes to its Surgeon Advisory Board (SAB) comprised of industry leaders in single access and robotic-assisted surgery. The SAB will work cohesively with management to advance the company’s Enos™ robotic single access surgical system through clinical studies to
